Four β-adrenoceptor subtypes in the mammalian heart

Trends in Pharmacological Sciences

Volumn 18, Issue 3, 1997, Pages 70-76

  Kaumann, Alberto J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DIHYDROXYPHENOXY) 3 (3,4 DIMETHOXYPHENETHYLAMINO) 2 PROPANOL; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHOXY]PHENYLACETIC ACID; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRANOLOL; CARAZOLOL; CYANOIODOPINDOLOL; CYANOPINDOLOL; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; NADOLOL; NORADRENALIN; PINDOLOL; PROCATEROL; PROPRANOLOL; RECEPTOR SUBTYPE; TIMOLOL; UNINDEXED DRUG; ZINTEROL; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;

COLON; DRUG RECEPTOR BINDING; HEART; HEART MUSCLE CONTRACTILITY; HUMAN; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVIEW; SMOOTH MUSCLE CONTRACTILITY;

EID: 0030909051     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(96)01033-4     Document Type: Article

References (61)

1. Gille, E., Lemoine, H., Ehle, B. and Kaumann, A. J. (1985) Naunyn-Schmiedeberg's Arch. Pharmacol. 331, 60-70
2. Kaumann, A. J. and Lemoine, H. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 403-411
3. Bristow, M. R. et al. (1986) Circ. Res. 59, 297-300
4. Hall, A. J., Petch, M. C. and Brown, M. J. (1991) Circ. Res. 66, 1610-1623
5. Kaumann, A. J. and Sanders, L. (1993) Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 536-540
6. Kaumann, A. J., Lynham, J. A., Sanders, L., Brown, A. M. and Molenaar, P. (1995) Pharmacol. Commun. 6, 215-222
7. Kaumann, A. J. et al. (1996) Mol. Cell. Biochem. 163/164, 112-123
8. DelMonte, F. (1993) Circulation 88, 854-863
9. Lemoine, H. and Kaumann, A. J. (1991) Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 56-69
10. Borea, P. A. et al. (1992) J. Mol. Cell. Cardiol. 24, 753-764
11. Xiao, R. P., Ji, X. W. and Lakatta, E. G. (1995) Mol. Pharmacol. 47, 322-329
12. Altschuld, R. et al. (1995) Circulation 92, 1612-1618
13. Kaumann, A. J., Hall, J. A., Murray, K. J., Wells, F. C. and Brown, M. J. (1989) Eur. Heart J. 10 (Suppl. B), 29-37
14. Green, S. A., Holt, B. D. and Liggett, S. B. (1992) Mol. Pharmacol. 41, 889-893
15. Levy, F. O., Zhu, X., Kaumann, A. J. and Birnbaumer, L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 19798-20802
16. Bristow, M. R., Hershberger, R. E., Port, J. D., Minobe, W. and Rasmussen, R. (1989) Mol. Pharmacol. 35, 295-303
17. Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E. and Lohse, M. J. (1993) Circulation 87, 454-463
18. Bristow, M. R. et al. (1993) J. Clin. Invest. 92, 2737-2745
19. Hall, J. A., Kaumann, A. J. and Brown, M. J. (1990) Circ. Res. 66, 1610-1623
20. Motomura, S., Deighton, N. M., Zerkowski, H. R., Michel, M. C. and Brodde, O-E. (1990) Br. J. Pharmacol. 101, 363-369
21. Sanders, L. et al. (1995) Circulation 92, 2526-2539
22. Sanders, L., Lynham, J. A. and Kaumann, A. J. (1996) Naunyn-Schmiedeberg's Arch. Pharmacol. 353, 661-670
23. Molenaar, P. et al. (1997) Br. J. Pharmacol. 120, 165-176
24. Kaumann, A. J. (1991) in Advances in Pharmacological Sciences (Szabadi, E. and Bradshaw, C.M., eds),pp. 221-230, Birkhäuser
25. Gauthier, C., Charpentier, F., Laurent, K. and Trochu, J-E. (1995) Circulation 92, 3965, 639
26. Gauthier, C., Tavernier, G., Charpentier, F., Languin, D. and Le Marec, H. (1996) J. Clin. Invest. 98, 556-562
27. Bond, R. and Clarke, D. R. (1988) Br. J. Pharmacol. 95, 723-734
28. Arch, J. R. S. and Kaumann, A. J. (1993) Med. Res. Rev. 13, 663-729
29. Chaudhry, A., MacKenzie, R. G., Feorgic, L. M. and Granneman, J. G. (1994) Cell. Signal. 6, 457-465
30. Begin-Heick, N. (1995) J. Cell Biochem. 58, 464-173
31. Krief, S. et al. (1993) J. Clin. Invest. 91, 344-349
32. Berkowitz, D. E. et al. (1995) Eur. J. Pharmacol. 289, 223-228
33. Nantel, F. et al. (1993) Mol. Pharmacol. 43, 548-555
34. Kaumann, A. J. (1989) Trends Pharmacol. Sci. 10, 316-320
35. Kaumann, A. J. (1996) Br. J. Pharmacol. 117, 93-98
36. Kaumann, A. J. and Molenaar, P. (1996) Br. J. Pharmacol. 118, 2085-2098
37. Malinowska, B. and Schlicker, E. (1996) Br. J. Pharmacol. 117, 943-949
38. Sarsero, D., Molenaar, P. and Kaumann, A. J. (1997) J. Mol. Cell. Cardiol 28, A274
39. Kaumann, A. J., Lynham, J. A., Sarsero, D. and Molenaar, P. (1997) Br. J. Pharmacol. 120, 102P
40. Lemoine, H. and Kaumann, A. J. (1983) Naunyn-Schmiedeberg's Arch. Pharmacol. 322, 111-120
41. Kaumann, A. J. (1986) Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 406-409
42. Man'Int Veld, A. J. and Schalekamp, M. A. D. H. (1981) Br. Med. J. 282, 229-231
43. Bearer, C. F., Knapp, R. D., Kaumann, A. J., Schwartz, T. L. and Birnbaumer, L. (1980) Mol. Pharmacol. 17, 328-338
44. Kaumann, A. J. (1983) Z. Kardiol. 72, 63-82
45. Kaumann, A. J. and Molenaar, P. Naunyn-Schmiedeberg's Arch. Pharmacol. (in press)
46. Strosberg, A. D. and Pietri-Rouxel, F. (1996) Trends Pharmacol. Sci. 17, 373-38347
47. Manara, L. et al. (1995) Pharmacol. Comm. 6, 253-258
48. Manara, L. et al. (1996) Br. J. Pharmacol. 117, 435-442
49. De Ponti, F. et al. (1996) Br. j. Pharmacol. 117, 1374-1376
50. Wheeldon, N. M., McDevitt, D. G. and Lipworth, B. J. (1993) Quart. J. Med. 86, 255-261
51. Kaumann, A. J. and Lynham, J. A. (1997) Br. J. Pharmacol. 120, 1187-1189
52. Kaumann, A. J., Lemoine, H., Morris, T. and Schwederski, U. (1982) Naunyn-Schmiedeberg's Arch. Pharmacol. 319, 216-221
53. Kaumann, A. J., Morris, T. and Bojar, H. (1983) J. Recept. Res. 3, 61-70
54. Dolan, J. A. et al. (1994) J. Pharmacol. Exp. Ther. 269, 1000-1006
55. Bianchetti, A. and Manara, L. (1990) Br. J. Pharmacol. 100, 831-839
56. Walter, M., Lemoine, H. and Kaumann, A. J. (1984) Naunyn-Schmiedeberg's Arch. Pharmacol. 327, 159-175
57. Kaumann, A. J., Morris, T. and Birnbaumer, L. (1979) Naunyn-Schmiedeberg's Arch. Pharmacol. 307, 1-8
58. Wang, T., Kaumann, A. J. and Brown, M. J. (1996) Br. J. Clin. Pharmacol. 42, 217-223
59. Lemoine, H., Ehle, B, and Kaumann, A. J. (1985) Naunyn-Schmiedeberg's Arch. Pharmacol. 331, 40-51
60. Kaumann, A. J. and Lobnig, B. M. (1986) Br. J. Pharmacol. 89, 207-218
61. Nanoff, C., Freissmuth, M. and Schütz, W. (1987) Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 519-525